United States · 
Who invested in SEngine Precision Medicine?
SEngine Precision Medicine's investors include National Institutes of Health.
United States · Series A startup
Who invested in SEngine Precision Medicine
Funding summaryUpdated 26 Oct 2026
$10Mraised across 1 round since 2022, from 1 source
- Latest round
- Series A, $10MJul 2022
- Investors
- 1
The rounds
- Jul 2022
Founders and team
From the SEC filings it signed: 3 on the team.
- Carla GrandoriExecutive Officer, Director, Promoteri
- Christopher KempExecutive Officer, Promoteri
- Tony HsuExecutive Officeri
On the board, as filediElliott BurklandPablo Prichard
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about SEngine Precision Medicine
How much has SEngine Precision Medicine raised?
SEngine Precision Medicine has raised $10M across 1 round since 2022.
When did SEngine Precision Medicine last raise?
SEngine Precision Medicine's most recent round was a Series A of $10M in Jul 2022.
What was SEngine Precision Medicine's biggest round?
Its most recent round, $10M in Jul 2022, is also its largest on record.
Who backed SEngine Precision Medicine first?
SEngine Precision Medicine's first round on record, in Jul 2022, was backed by National Institutes of Health.
What stage is SEngine Precision Medicine at?
SEngine Precision Medicine's latest named round is a Series A, in Jul 2022.
Where is SEngine Precision Medicine based?
SEngine Precision Medicine is based in the United States.
Companies like SEngine Precision Medicine
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.